We are live on ! Find out more
OP

Omni Partners Portfolio holdings

AUM $2.03B
1-Year Est. Return 126.33%
This Fund
S&P 500
This Quarter Est. Return
+15.53%
1 Year Est. Return
+126.33%
3 Year Est. Return
+411.65%
5 Year Est. Return
+1,549.93%
10 Year Est. Return
AUM
$3.73M
AUM Growth
-$1.38B
Cap. Flow
-$103M
Cap. Flow %
-2,765.76%
Top 10 Hldgs %
92.1%
Holding
54
New
24
Increased
5
Reduced
5
Closed
12

Sector Composition

Rank Sector Weight
1 Technology 37.07%
2 Healthcare 8.3%
3 Consumer Discretionary 4.6%
4 Energy 2.98%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GEN icon
1
Gen Digital
GEN
$16.1B
$1.34M 35.89%
2,015,595
+916,113
+83% +$22.4M
GRAF.WS
2
DELISTED
Graf Industrial Corp. Warrants (each exercisable for three-quarters of one share of common stock, ea
GRAF.WS
$1M 26.87%
+2,288,144
New +$962K
AGN
3
DELISTED
Allergan plc
AGN
$216K 5.79%
1,129,960
+8,494
+0.8% +$1.53M
MDCO
4
DELISTED
Medicines Co
MDCO
$196K 5.26%
+2,311,536
New +$154M
WCG
5
DELISTED
Wellcare Health Plans, Inc.
WCG
$192K 5.15%
581,479
+144,355
+33% +$43.3M
ZAYO
6
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$168K 4.51%
4,853,916
-293,924
-6% -$10.1M
CZR
7
DELISTED
Caesars Entertainment Corporation
CZR
$139K 3.72%
10,208,037
+1,567,066
+18% +$19.8M
TGE
8
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
$103K 2.75%
+4,644,420
New +$89.1M
WMGI
9
DELISTED
Wright Medical Group Inc
WMGI
$41.2K 1.1%
+1,350,350
New +$35.4M
RARX
10
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$39.4K 1.06%
+839,902
New +$37.1M
AMTD
11
DELISTED
TD Ameritrade Holding Corp
AMTD
$32K 0.86%
+644,087
New +$27.9M
CY
12
DELISTED
Cypress Semiconductor
CY
$26.5K 0.71%
1,134,786
-4,612,120
-80% -$108M
DM
13
DELISTED
Desktop Metal, Inc.
DM
$24.5K 0.66%
245,285
VLDR
14
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$23.3K 0.63%
2,287,893
-251
-0% -$2.54K
HGV icon
15
Hilton Grand Vacations
HGV
$3.79B
$20.8K 0.56%
603,433
+475,773
+373% +$16.4M
LPT
16
DELISTED
Liberty Property Trust
LPT
$18.9K 0.51%
+314,926
New +$18M
MLNX
17
DELISTED
Mellanox Technologies, Ltd.
MLNX
$13K 0.35%
110,628
-341,757
-76% -$38.8M
ALUS.U
18
DELISTED
Alussa Energy Acquisition Corp
ALUS.U
$12.1K 0.32%
+1,200,000
New +$12.1M
WBC
19
DELISTED
WABCO HOLDINGS INC.
WBC
$11.9K 0.32%
88,031
-5,503
-6% -$742K
SAMAU
20
DELISTED
Schultze Special Purpose Acquisition Corp. Unit
SAMAU
$11.4K 0.31%
1,090,193
PIC.U
21
DELISTED
Pivotal Investment Corporation II Units, each consisting of one share of Class A common stock and on
PIC.U
$10.4K 0.28%
1,019,358
DMS
22
DELISTED
Digital Media Solutions, Inc.
DMS
$10.3K 0.28%
66,461
VRT icon
23
Vertiv
VRT
$112B
$8.82K 0.24%
+800,000
New +$8.35M
HPK icon
24
HighPeak Energy
HPK
$931M
$8.55K 0.23%
824,837
ARQL
25
DELISTED
Arqule Inc
ARQL
$8.27K 0.22%
+414,055
New +$4.8M

Similar funds

Omni Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Omni Partners held 54 positions worth $3.73M, down 100% from $1.38B the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Omni Partners withdrew a net $103M in Q4 2019, closing 12 positions and reducing 5 holdings. Its most notable exit was Celgene Corp, an estimated $243M position sold in full.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Omni Partners opened a new position in Medicines Co worth $196K.

  • Omni Partners's largest Q4 2019 buy was Medicines Co: 2,311,536 shares worth $196K.
  • Omni Partners added most to Wellcare Health Plans, Inc. in Q4 2019, an estimated $43.3M increase.
  • Omni Partners's biggest Q4 2019 reduction was Cypress Semiconductor, cutting an estimated $108M.
  • Omni Partners fully exited Celgene Corp in Q4 2019, selling an estimated $243M.
  • Omni Partners's ten largest holdings make up 92% of its $3.73M portfolio in Q4 2019.
  • Omni Partners opened 24 new positions and closed 12 in Q4 2019.
  • Omni Partners's portfolio value fell 100% quarter-over-quarter to $3.73M.

Based on Omni Partners's 13F filing for Q4 2019, filed 13 Feb 2020.